Clinical Report: Fibromyalgia Among Cancer Patients: A Comprehensive Review
Overview
This systematic review highlights the prevalence and clinical significance of fibromyalgia (FM) among cancer patients, revealing its impact on pain perception, Health-Related Quality of Life (HRQoL), and treatment adherence. The findings underscore the need for integrated management strategies in oncology to address the complexities of FM as a comorbidity.
Background
Fibromyalgia is a chronic syndrome characterized by widespread pain, fatigue, and sleep disturbances, affecting a significant portion of the population, particularly women aged 30 to 60. In cancer patients, the overlap of FM symptoms with cancer-related symptoms complicates diagnosis and treatment, making it crucial to understand FM's role in this population. Recognizing FM as a relevant comorbidity in oncology is essential for improving patient outcomes and quality of life.
Data Highlights
No quantitative synthesis was possible due to the heterogeneous nature of the included studies.
Key Findings
FM does not increase cancer risk but contributes to pain amplification and higher symptom burden.
Patients with FM experience reduced Health-Related Quality of Life (HRQoL) and impaired treatment adherence.
Pre-existing nociplastic pain features are linked to premature discontinuation of oncological therapies.
The overlap between FM-related and cancer-related symptoms poses significant diagnostic challenges.
Moderate to high risk of bias was noted in the studies reviewed, indicating a need for higher-quality research.
Clinical Implications
Healthcare professionals should be aware of the significant impact of fibromyalgia on cancer patients, particularly regarding pain management and treatment adherence. Integrated management strategies that address both FM and cancer-related symptoms are essential for optimizing patient care.
Conclusion
The review emphasizes the importance of recognizing fibromyalgia as a significant comorbidity in oncology, highlighting the need for further research to develop effective management strategies tailored to this patient population.
by Melania Prete, Giuseppe Porciello, Elvira Palumbo, Sara Vitale, Maurizio Marchesini, Sabrina Bimonte, Francesco Del Prato, Arturo Cuomo, Marco Cascella, Maria Grimaldi, Natalia Russo, Assunta Luongo, Anna Crispo
